Follow the Induct AS stock price and the full directors' dealings record of the company, a listed equity based in Norway. Shares are listed on the NO market, under the authority of Oslo Børs. Operating in the Health Care sector, Induct AS has published 19 reports. Market capitalisation: €28.4m. The latest transaction was filed on 20 August 2026 (Sale). Among the most active insiders: Selskapet Kimpot AS. All data is free.
19
Insider Decl.
n/a
Thresholds
€4,473
7 ops.
Buy Volume
€10,400
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Induct AS Buy (bullish), based on 1 analysts. Average price target: NOK 1.00.
27Σ signal
Buys €4,473€10,400 Sells
Fundamental score
Ranked 18,471 of 28,932 companies
43.3
score / 100
Value
39
Quality
48
FCF yld-9.4%
Earn yld-20%
EV/EBITDA5.3x
ROE-25%
Gross mgn93%
Net mgn-48%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,500 shares@ NOK 8.73100.0% of flowShareMERKOSLO:532638
19 of 19 declarations
About Induct AS
Induct AS is a company operating in the healthcare and pharmaceutical sector, specializing in the development of innovative solutions. It is listed on the XOSL market.